GNNSF Stock Latest News
Company AnnouncementsGenscript Discloses Legend Biotech Third-Quarter 2026 Results3d ago
Company AnnouncementsLegend Biotech to Present Cell-Therapy Data at ASH 20261w ago
Company AnnouncementsGenScript Clarifies Trading-Counter Change Amid Share-Price Volatility1w ago
Company AnnouncementsGenScript Biotech Reports Death of Company Secretary1w ago
Company AnnouncementsLegend Biotech Posts US$710 Million Quarterly Sales for CARVYKTI1M ago
Company AnnouncementsGenscript Biotech Halves Trading Lot Size to Boost Liquidity on Hong Kong Market1M agoCompany AnnouncementsGenscript Biotech Joins Lilly’s AI Drug Discovery Platform Amid Share Price Surge1M ago
Company AnnouncementsGenscript Biotech Details Board and Committee Structure in Governance Update1M ago
Company AnnouncementsGenscript Biotech Raises HK$2.33 Billion Through Hong Kong Share Placing1M ago
Company AnnouncementsGenscript Biotech to Raise HK$2.33 Billion via Discounted Share Placing for AIDD Expansion2M ago
Company AnnouncementsGenScript Biotech Updates Cayman Islands Corporate Service Provider Names2M ago
Company AnnouncementsGenscript Plans Hong Kong Spin-Off Listing for Probio Technology2M ago
Company AnnouncementsGenscript Biotech Posts Strong Core Growth but Reports Interim Loss on Legend Impact2M ago
Company AnnouncementsGenscript Highlights Legend Biotech’s Q2 Results and Cautions Investors3M ago
Company AnnouncementsGenscript Biotech Sets August Board Meeting to Approve Interim Results3M ago- Company AnnouncementsGenscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution4M ago
Company AnnouncementsGenScript Associate Legend Biotech Reports Promising In Vivo CAR-T Data in B-Cell Lymphoma5M agoCompany AnnouncementsGenscript Biotech Grants 14.7 Million RSUs to Strengthen Long-Term Incentives5M ago